CIK 0001080014
- Large accelerated filer
Innoviva, Inc.
Sign in to watch- Ticker
- INVA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 943265960
- Phone
- +1 650-238-9600
- Business address
- 1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
- Former names
- THERAVANCE INC, ADVANCED MEDICINE INC
- 4 Grant or award Director acquired 13,923 shares (grant or award)
- 4 Grant or award Director acquired 13,923 shares (grant or award)
- 4 Grant or award Director acquired 13,923 shares (grant or award)
- 4 Grant or award Director acquired 13,923 shares (grant or award)
- 4 Grant or award Director acquired 13,923 shares (grant or award)
- 4 Shares withheld for taxes Ronsheim Matthew gave up 268 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 976 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Grant or award Chief Financial Officer acquired 12,096 shares (grant or award)
- 4 Grant or award Ronsheim Matthew acquired 12,768 shares (grant or award)
- 4 Grant or award Chief Accounting Officer acquired 10,752 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Ronsheim Matthew gave up 807 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Accounting Officer gave up 2,862 shares (to pay taxes)
- 4 Shares withheld for taxes Ronsheim Matthew gave up 1,600 shares (to pay taxes)
- 3 Insider Initial Statement of Ownership
- 4 Shares withheld for taxes Chief Accounting Officer gave up 784 shares (to pay taxes)
- 4 Open-market sale Chief Accounting Officer sold 10,994 shares at an average $13.99 ($153,810)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 3 of 39 · 776 filings